Valuation: Compumedics Limited

Market Cap 4.39Cr 3.07Cr 2.68Cr 2.47Cr 2.28Cr 4.3Cr 295.53Cr 30Cr 12Cr 144.74Cr 12Cr 11Cr 498.25Cr P/E 2026 *
14.7x
P/E 2027 * 5.95x
Enterprise Value 4.39Cr 3.07Cr 2.68Cr 2.47Cr 2.28Cr 4.3Cr 295.53Cr 30Cr 12Cr 144.74Cr 12Cr 11Cr 498.25Cr EV / Sales 2026 *
0.66x
EV / Sales 2027 * 0.55x
Free-Float
36.04%
Yield 2026 *
-
Yield 2027 * 9.09%
1 day-2.22%
1 week-4.35%
Current month-13.73%
1 month-16.98%
3 months-21.43%
6 months-33.33%
Current year-34.33%
1 week 0.22
Extreme 0.22
0.23
1 month 0.22
Extreme 0.22
0.3
Current year 0.22
Extreme 0.22
0.45
1 year 0.22
Extreme 0.22
0.45
3 years 0.15
Extreme 0.15
0.45
5 years 0.14
Extreme 0.135
0.49
10 years 0.14
Extreme 0.135
0.96
Manager TitleAgeSince
Chief Executive Officer 67 16/12/2010
Director of Finance/CFO 61 11/11/2009
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 67 16/12/2010
Director/Board Member 61 01/01/2000
Director/Board Member - 27/10/2022
Change 5-day change 1-year change 3-year change Capi.($)
-2.22%-4.35%-21.43%+18.92% 3.07Cr
-1.97%+1.03%+25.30%+1.37% 20TCr
-0.58%+2.40%+4.64%-14.27% 14TCr
-14.15%-15.08%-33.08%-2.38% 12TCr
-1.32%-1.65%-57.93%-16.31% 6.54TCr
-2.40%-7.03%+12.54%-7.47% 4.94TCr
-0.11%+1.53%-24.62%-31.81% 4.47TCr
-3.41%-2.11%+12.98%+11.17% 3.71TCr
-2.44%-1.98%+24.27%+36.75% 3.62TCr
-4.00%-2.52%-17.27%-22.32% 2.87TCr
Average -1.78%-2.50%-7.46%-2.63% 7.26TCr
Weighted average by Cap. -1.33%-1.83%-2.45%-5.28%

Financials

2026 *2027 *
Net sales 6.63Cr 4.63Cr 4.05Cr 3.73Cr 3.44Cr 6.49Cr 445.83Cr 45Cr 18Cr 218.35Cr 17Cr 17Cr 751.67Cr 7.97Cr 5.57Cr 4.86Cr 4.49Cr 4.14Cr 7.8Cr 535.94Cr 54Cr 21Cr 262.48Cr 21Cr 20Cr 903.59Cr
Net income 38L 26.53L 23.19L 21.4L 19.72L 37.17L 26Cr 2.56Cr 1.01Cr 13Cr 99.65L 97.46L 43Cr 90L 62.84L 54.92L 50.68L 46.71L 88.05L 61Cr 6.06Cr 2.38Cr 30Cr 2.36Cr 2.31Cr 102.04Cr
Net Debt - -
Logo Compumedics Limited
Compumedics Limited is an Australia-based medical device company which is involved in the development, manufacture, and commercialization of diagnostics technology for sleep, brain and ultrasonic blood flow monitoring applications. Its geographic segments include the Americas, Australia and Asia Pacific, and Europe and the Middle East. It sells all of its product offerings in this region, including sleep diagnostic systems, clinical electroencephalograms (EEG systems), brain monitoring systems, ultrasonic blood-flow systems, supplies and technical service and support. It provides Sleep Diagnostics and Neurology Diagnostics Solutions. Its products include Compumedics Siesta, Compumedics Somfit, Compumedics Somte PSG and others. It provides a range of solutions for the neurology laboratory, from clinical epilepsy monitoring applications to Transcranial Doppler Sonography. Its other products include Grael 4K PSG, Falcon HST, Okti, Neuvo 64-512 Channel LTM EEG and others.
Employees
175
Date Price Change Volume
17/26/17 A$0.2200 -2.22% 6,250
16/26/16 A$0.2250 0.00% 85,374
15/26/15 A$0.2250 -2.17% 22,683
14/26/14 A$0.2300 0.00% 8,694
13/26/13 A$0.2300 0.00% 43,241
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.2200AUD
Average target price
0.8000AUD
Spread / Average Target
+263.64%

Annual profits - Rate of surprise